Disseminated peritoneal leiomyomatosis (DPL) is a rare benign disease characterized
by tumors derived from smooth muscles occurring in the abdominal cavity. This
condition is thought to be associated with an elevated estrogen level, such as that
caused by pregnancy, estrogen replacement therapy, oral contraceptives, and ovarian
endocrine tumors.[1] DPL frequently occurs in women of reproductive age, and its growth patterns
can resemble those of malignant tumors with active growth. Thus, DPL is easily
misdiagnosed prior to surgery. A definitive diagnosis depends on the operative,
histopathologic, and immunohistochemical findings. We herein describe a 45-year-old
woman with DPL following laparoscopic uterine myomectomy. This case report provides
us with a new perspective on the identification of abdominal swelling and reminds us
that it is important to pay attention to the patient’s history, especially the
surgical history.
Case report
A 45-year-old woman who had undergone laparoscopic uterine myomectomy 10 years
previously was found to have abdominal masses on imaging during a routine medical
checkup. Pathological examination at that time confirmed a diagnosis of uterine
fibroids accompanied by red changes and slight bleeding. She had no history of
hormonal therapy or contraception. During the medical checkup 10 years after the
myomectomy, a computed tomography (CT) scan revealed a 4.3- × 5.1-cm mass in the
ascending colon that was suspected to be a malignant or stromal tumor. A second
2.5- × 3.3-cm mass between the liver and right kidney was assumed to be metastatic
spread (Figure 1). Both of
the masses were intraperitoneal. However, enteroscopy revealed no abnormalities. The
patient underwent a positron emission tomography/CT scan to rule out the possibility
of a gastrointestinal stromal tumor (GIST). The maximum standardized uptake value
(SUVmax) of the two masses were 2.6 and 1.6 Bq/mL, respectively. The SUVmax of GISTs
usually ranges from 2.0 to 2.5 Bq/mL, and a malignant tumor is highly likely when
the SUVmax is >2.5 Bq/mL.
Figure 1.
Computed tomography scan revealing the two masses. The left figure shows the
extramural colonic mass, and the right figure shows the mass between the
liver and right kidney.
Computed tomography scan revealing the two masses. The left figure shows the
extramural colonic mass, and the right figure shows the mass between the
liver and right kidney.Considering the rapid growth rate and uncertainty of the malignant potential of the
masses, the patient underwent laparotomy and mass resection. During the surgery, we
found that the larger mass was located outside of the colon lumen, originated from
the peritoneum, and adhered to the surface of the ascending colon (Figure 2); this was in
contrast to the CT findings, which indicated that the tumor was located in the lumen
of the ascending colon. The smaller mass was located in the retroperitoneal space.
The excised specimens are shown in Figure 3. The final histopathological examination confirmed a diagnosis
of leiomyoma (Figure 4)
(CD34 and CD117 negativity, which are inconsistent with the characteristics of
GISTs, and smooth muscle actin and desmin positivity, which are consistent with
smooth muscle tumors).
Figure 2.
Intraoperative findings. The larger mass was located outside of the colon
lumen, adhering to the surface of the ascending colon. The smaller mass was
located in the retroperitoneal space.
Figure 3.
The histological appearance of both masses was compatible with the
characteristics of a leiomyoma (hematoxylin and eosin staining).
Immunohistochemistry revealed negativity for CD34, CD117, DOG-1, S-100, and
succinate dehydrogenase subunit B; positivity for smooth muscle actin and
desmin; and a Ki-67 index of 5%.
Figure 4.
Excised mass specimens. The specimens were soft, yellow masses with a uniform
texture.
Intraoperative findings. The larger mass was located outside of the colon
lumen, adhering to the surface of the ascending colon. The smaller mass was
located in the retroperitoneal space.The histological appearance of both masses was compatible with the
characteristics of a leiomyoma (hematoxylin and eosin staining).
Immunohistochemistry revealed negativity for CD34, CD117, DOG-1, S-100, and
succinate dehydrogenase subunit B; positivity for smooth muscle actin and
desmin; and a Ki-67 index of 5%.Excised mass specimens. The specimens were soft, yellow masses with a uniform
texture.
Discussion
The etiology of DPL is unclear. DPL was first reported in 1952 by Willson and Peale,[2] and only about 100 cases have since been reported. Most researchers believe
that DPL is related to increases in the estrogen level in the body.[3] In recent years, however, accumulating evidence suggests that iatrogenic
factors are important causes of DPL. Few reports have described DPL after myomectomy
or hysterectomy; however, DPL has been reported following myomectomy or hysterectomy
using laparoscopic surgery.[4] Residual myoma fragments produced during surgery may implant into normal
tissue and continue to grow by forming new blood vessels between normal
tissues.[5,6]
Patients with DPL have normal tumor markers and no specific imaging findings, nor do
they have special clinical manifestations or signs. Approximately 50% of patients
are asymptomatic, while the remaining patients develop pelvic pain, pelvic cavity
discomfort, pelvic and abdominal compression symptoms, and even intestinal obstruction.[7] This lack of specific characteristics results in a very high rate of
preoperative misdiagnosis. The definitive diagnosis depends on intraoperative
examination findings and pathological results. Several differences exist between DPL
and other gastrointestinal tumors such as GISTs. The main pathological manifestation
of DPL is dense arrangement of smooth muscle cells and fibroblasts.
Immunohistochemical examination often reveals smooth muscle actin and desmin
positivity. GISTs generally consist of spindle cells and epithelial-like cells with
CD117CD34 positivity, and most of the spindle cells have unclear boundaries.
Pathological examination can generally determine the tumor type.In the present case, CT revealed that one of the masses was located in the ascending
colon in close proximity to the adjacent intestinal wall, with its outer part close
to the peritoneum. Considering its rapid growth rate, it was suspected to be a
malignant tumor. We also considered that this mass could be a GIST, which is the
most common mesenchymal tumor in the gastrointestinal tract and can occur in any
part of the gastrointestinal tract.[8] GISTs also lack specific clinical manifestations and usually present as round
masses with a smooth rim on CT images. The smaller mass between the liver and right
kidney was assumed to be metastatic spread.During the intraoperative exploration of the relationship between the larger mass and
the peripheral tissue, we found that the mass had not grown on the wall of the
intestine but had instead originated from the peritoneum. The intestinal wall was
squeezed inward with the tumor growth, explaining why it was closely related to the
intestinal wall on the CT image. Histopathological examination revealed that both of
the masses were leiomyomas. Considering the patient’s history of laparoscopic
uterine myomectomy, we believe that these two masses were DPL possibly caused by the
spread of tumor cells by uterine myomectomy. In most other cases, patients have been
diagnosed with DPL no more than 10 years after uterine myomectomy. In the present
case, however, the patient had undergone uterine myomectomy 10 years previously.
This case suggests that even many years after surgery, regular medical examinations
are required to detect the occurrence of DPL.
Conclusion
DPL is a very rare disease that can develop after myomectomy. DPL should be
considered as a differential diagnosis of intra-abdominal masses in patients with a
history of myomectomy. Care should be taken during laparoscopic extraction of
myomas.
Abbreviations
DPL: disseminated peritoneal leiomyomatosis, GIST: gastrointestinal stromal tumor;
CT: computed tomography; SUVmax: maximum standardized uptake value
Authors: Zehra Ordulu; Paola Dal Cin; Wilson W S Chong; Kwong Wai Choy; Charles Lee; Michael G Muto; Bradley J Quade; Cynthia C Morton Journal: Genes Chromosomes Cancer Date: 2010-12 Impact factor: 5.006
Authors: John A Harris; Carolyn W Swenson; Shitanshu Uppal; Neil Kamdar; Nichole Mahnert; Sawsan As-Sanie; Daniel M Morgan Journal: Am J Obstet Gynecol Date: 2015-08-24 Impact factor: 8.661
Authors: Albino Eccher; Amedeo Carraro; Ilaria Girolami; Manuela Villanova; Alex Borin; Paola Violi; Barbara Paro; Claudia Mescoli; Deborah Malvi; Luca Novelli; Antonietta D'Errico; Giuseppe Rossini; Marco Ungari Journal: Am J Case Rep Date: 2021-02-13